Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > REGULATORY
REGULATORY
- PMDA Reviewing Osteoporosis Treatment Forteo for Risk of Shock, Anaphylaxis
June 17, 2014
- “Annual” NHI Price Revision Erased from Gov’t Draft Policy Blueprint
June 16, 2014
- Regulatory Reform Proposal Including Expansion of Mixed Care Use Submitted to Prime Minister
June 16, 2014
- LDP Members with Vested Interests Slam Annual NHI Price Revision
June 12, 2014
- MHLW Panel OKs Draft Report on Medical Database Project, but Further Discussion Needed for Drug Makers’ Usage
June 12, 2014
- Expansion of “Mixed Care” Cited in Outline for New Growth Strategy
June 12, 2014
- MHLW to Seek Opinions on Abe’s New Mixed Care Plan from Advisory Panels
June 11, 2014
- PM Abe Vows to Forge New System to Accelerate Mixed Care
June 11, 2014
- Health Minister Still Cautious about Annual Drug Price Revision
June 11, 2014
- Ex-Novartis Employee Nabbed over Diovan Data Tampering: Reports
June 11, 2014
- Govt Tilting Toward Etching Annual NHI Price Revision in Fiscal Blueprint
June 10, 2014
- No Complaints Received So Far for Penalty Fee Cuts: MHLW Official
June 10, 2014
- Japan Sees 53-Month Designation Lag, 54-Month Approval Lag for Orphan Drugs
June 9, 2014
- MHLW Designates 20 Products including Allegra FX as Drugs Requiring Face-to-Face Consultations
June 9, 2014
- Researchers Aiming to Craft Guide for Ultra-Orphan Drug Development
June 9, 2014
- JRCS to Use Nucleic Acid Testing on Individual Samples of Donated Blood: PAFSC Committee
June 9, 2014
- MHLW Rejects Proposal to Abolish Market Expansion Re-Pricing Rule
June 6, 2014
- LDP Members with Vested Interests to Oppose Annual Drug Price Revision
June 6, 2014
- MHLW, Pharma Officials Take to Nagata-cho in Crusade against Yearly NHI Price Revision
June 6, 2014
- MHLW Gets Ball Rolling on OTC Diagnostics Deregulation
June 5, 2014
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…